Cavatar LLC
Biotech · Private
Humanized monoclonal antibody targeting caveolae for tumor-specific chemotherapy delivery
cavatar-sd.com →- Grants
- $1.2M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel Reagents for Breast Tumor SPECT Imaging | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Caveolae Targeted Cisplatin Immunoconjugates for Effective Lung Cancer Therapy | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Caveolae-Targeted Cisplatin Immunoconjugates for Effective Lung Cancer Therapy | $299,999 | |
| Federal grant | Department of Health and Human Services · Phase I · I- Corps Administrative Supplement to Novel Reagents for Breast Tumor SPECT Imaging R41CA217546 | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Clinical Translation of a Caveolae Targeting Antibody for Enhancing Cancer Drug Delivery | $300,001 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1305 | Immunomedics | — | — |
| 1306 | INVENIO THERAPEUTICS INC | — | — |
| 1307 | CONFOMETRX, INC. | — | — |
| 1308 | Cavatar LLC | — | — |
| 1309 | COARE BIOTECHNOLOGY, INC. | — | — |
| 1310 | Pinnacle Medicines | — | — |
| 1311 | Riptide Bioscience, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.